Tactile Systems Technology Inc (TCMD)
Tactile Systems Technology, Inc. is a healthcare company focused on medical technology for underserved chronic conditions in the United States. The company develops and supplies devices used in the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiency, chronic edema, leg ulcers, and related conditions. Its product portfolio includes Flexitouch Plus, a pneumatic compression system; Entre Plus, an at-home compression device; Nimbl, a platform for upper-extremity lymphedema; Kylee, a mobile application designed to support patient education and symptom tracking; and AffloVest, a portable chest wall oscillation vest used for patients with retained pulmonary secretions associated with bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Incorporated in 1995, the company is headquartered in Minneapolis, Minnesota, and its common stock trades on the NASDAQ under the symbol TCMD.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TCMD
|
$28.45
|
25.5% Upside
|
Undervalued
|
$39
|
72.0% Upside
|
Bargain
|
Great
|
0.0%
|
November 9, 2026
|
20.8x
|
2.3x
|
1.5x
|
513.8 M
|
462.1 M
|
2.7%
|
90.8%
|
9.1
|
107.9%
|
